admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Field Trip Health & Wellness Obtains CCAA Protection

Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted...

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on...

PT400 – Beckley Retreats: Combining Modern Science, Tradition, and Holistic Wellness

Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in...

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia

Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration...

Algernon Pharmaceuticals Announces Launch of Rights Offering

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine...

1...777879...218 Page 78 of 218

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin